22nd Century Group (Nasdaq: XXII) has acquired GVB Biopharma. Read the press release here
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 01/24/23 | 8-K | Current report filing |
|
   |
3 |
| 11/21/22 | 8-K | Current report filing |
|
|
3 |
| 11/17/22 | 3 | Initial statement of beneficial ownership of securities |
|
2 | |
| 11/17/22 | 8-K | Current report filing |
|
|
2 |
| 11/08/22 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
45 |
| 11/08/22 | 8-K | Current report filing |
|
|
35 |
| 09/22/22 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 09/15/22 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
10 | |
| 09/14/22 | EFFECT | Notice of Effectiveness |
|
1 | |
| 09/12/22 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
1 |
